Viewing Study NCT06698692


Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2025-12-25 @ 1:43 PM
Study NCT ID: NCT06698692
Status: RECRUITING
Last Update Posted: 2024-11-21
First Post: 2024-11-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module